IL-8 is an independent prognostic factor irrespective of treatment.
There is an interaction between HGF and treatment arm.
Certain subgroups based on IL-8/HGF levels seemed to do better with TPZ/CIS while others did worse, highlighting the complexity of hypoxia targeting in unselected patients.
2012-03-16
Eng.
Clinical cancer research : an official journal of the American Association for Cancer Research
Radiation Oncology & Pathology, Stanford University, Stanford, CA, USA. qle [at] stanford.edu
Clin Cancer Res. 2012 Mar;18(6):1798-807
© Galenicom 1999-2013